IP Library Granted Patent US 10,280,405
Granted Patent B2
US 10,280,405 · App. 15/913,058 · Granted May 7, 2019

Methods of propagating rhinovirus C in previously unsusceptible cell lines

Inventors: James E. Gern (Madison, WI); Yury A. Bochkov (Fitchburg, WI); Ann C. Palmenberg (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C12N7/00C07K14/705G01N33/5014C12N2770/32751G01N2333/095G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,280,405
App. No.
15/913,058
Granted
May 7, 2019
Kind
B2
Abstract

The present invention provides methods of propagating rhinovirus C (RV-C) in a host cell; a host cell comprising an effective amount of a heterologous CDHR3 receptor such that the host cell can support propagation of rhinovirus C; and kits comprising at least one host cell previously unable to support rhinovirus C growth, wherein the host cell comprises a heterologous CDHR3 receptor and a sample of rhinovirus C. Methods of use are also provided.

Claims (12)

1. A kit comprising:

a. at least one host cell able to support rhinovirus C replication, wherein the host cell comprises a heterologous CDHR3 receptor; and

b. a sample of rhinovirus C or rhinovirus C variant.

2. The kit of claim 1 wherein the host cell is selected from the group consisting of NCI-H358, WI-38, WisL, HEK293T, BEAS-2B, A549 and HeLa.

3. The kit of claim 1 wherein the CDHR3 receptor is a CDHR3-C529Y variant.

4. A kit comprising:

a. a nucleic acid encoding a CDHR3 receptor; and

b. a sample of rhinovirus C.

5. The kit of claim 4 wherein the CDHR3 receptor is a CDHR3-C529Y variant.

6. A host cell infected with rhinovirus C or rhinovirus C variant, wherein the host cell has been modified to express an effective amount of a CDHR3 receptor and support propagation of rhinovirus C.

7. The host cell of claim 6 wherein the CDHR3 receptor is a CDHR3-C529Y variant.

8. The transfected cell of claim 6 wherein the host cell is a cell able to support rhinovirus C replication.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 16, 2018
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045616/0608 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2018
From: GERN, JAMES; BOCHKOV, YURY; PALMENBERG, ANN
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 045190/0057 →
Continuity (4)
Division 14836327 · Aug 26, 2015
Provisional Application 62043517 · Aug 29, 2014
Provisional Application 62203603 · Aug 11, 2015
Related Publication 20190055521A1 · Feb 21, 2019
Cited By (1)
US 12,428,462